SOX2 Expression and Transcriptional Activity Identifies a Subpopulation of Cancer Stem Cells in Sarcoma with Prognostic Implications
Open Access
- 12 April 2020
- Vol. 12 (4), 964
- https://doi.org/10.3390/cancers12040964
Abstract
Stemness in sarcomas is coordinated by the expression of pluripotency factors, like SOX2, in cancer stem cells (CSC). The role of SOX2 in tumor initiation and progression has been well characterized in osteosarcoma. However, the pro-tumorigenic features of SOX2 have been scarcely investigated in other sarcoma subtypes. Here, we show that SOX2 depletion dramatically reduced the ability of undifferentiated pleomorphic sarcoma (UPS) cells to form tumorspheres and to initiate tumor growth. Conversely, SOX2 overexpression resulted in increased in vivo tumorigenicity. Moreover, using a reporter system (SORE6) which allows to monitor viable cells expressing SOX2 and/or OCT4, we found that SORE6+ cells were significantly more tumorigenic than the SORE6- subpopulation. In agreement with this findings, SOX2 expression in sarcoma patients was associated to tumor grade, differentiation, invasive potential and lower patient survival. Finally, we studied the effect of a panel of anti-tumor drugs on the SORE6+ cells of the UPS model and patient-derived chondrosarcoma lines. We found that the mithramycin analogue EC-8042 was the most efficient in reducing SORE6+ cells in vitro and in vivo. Overall, this study demonstrates that SOX2 is a pro-tumorigenic factor with prognostic potential in sarcoma. Moreover, SORE6 transcriptional activity is a bona fide CSC marker in sarcoma and constitutes an excellent biomarker for evaluating the efficacy of anti-tumor treatments on CSC subpopulations.Funding Information
- Instituto de Salud Carlos III (CPII16/00049, CD16/00103, PI16/00280, PI19/00560, CB16/12/00390)
- Gobierno del Principado de Asturias (IDI/2018/155, BP-17-108)
This publication has 51 references indexed in Scilit:
- Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerNature Genetics, 2012
- Modeling sarcomagenesis using multipotent mesenchymal stem cellsCell Research, 2011
- Sox2 maintains self renewal of tumor-initiating cells in osteosarcomasOncogene, 2011
- Sox2 expression in breast tumours and activation in breast cancer stem cellsOncogene, 2011
- Synovial Sarcoma Is a Stem Cell MalignancyThe International Journal of Cell Cloning, 2010
- EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cellsGenes & Development, 2010
- Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in OsteosarcomaCancer Research, 2009
- Identification of Cancer Stem Cells in Ewing's SarcomaCancer Research, 2009
- Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy productionProceedings of the National Academy of Sciences of the United States of America, 2007
- Reciprocal Transcriptional Regulation of Pou5f1 and Sox2 via the Oct4/Sox2 Complex in Embryonic Stem CellsMolecular and Cellular Biology, 2005